Literature DB >> 6187938

Genomic RNA of mengovirus. VI. Translation of its two cistrons in lysates of interferon-treated cells.

A M Degener, P Pagnotti, J Facchini, R Pérez-Bercoff.   

Abstract

The addition of low levels (40 ng/ml) of the synthetic double-stranded polyribonucleotide poly I:C to lysates of interferon-treated L-cells resulted in a strong inhibition (70 to 75%) of the in vitro translation of mengovirus RNA. Under these conditions, the rates of incorporation of [35S]methionine or formyl-[35S]methionine were depressed to a comparable extent. The sequences of mengovirus RNA recognized by ribosomes of interferon-treated cells at initiation of translation were compared with those present in initiation complexes formed by ribosomes of untreated controls. Fingerprint analysis revealed that the same sequences of mengovirus RNA were protected against nuclease attack by the 80S and the 40S initiation complexes formed in vitro in lysates of control or interferon-treated L-cells. Mengovirus RNA-coded proteins were labeled at their N-terminal end with formyl-[35S]methionine and digested to completion with trypsin. The resulting fragments were separated by high-voltage paper electrophoresis. Two different formyl-[35S]methionine-labeled N termini were resolved. Further analyses supported the notion that the two radioactive peaks originated in the initiation of translation at two different sites. This pattern did not change when mengovirus RNA was translated in lysates of interferon-treated cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187938      PMCID: PMC256487     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Capping of eucaryotic mRNAs.

Authors:  A J Shatkin
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  In vitro translation of mengovirus RNA deprived of the terminally-linked (capping?) protein.

Authors:  R Perez Bercoff; M Gander
Journal:  FEBS Lett       Date:  1978-12-15       Impact factor: 4.124

3.  Translation of poliovirus RNA in vitro: detection of two different initiation sites.

Authors:  M L Celma; E Ehrenfeld
Journal:  J Mol Biol       Date:  1975-11-15       Impact factor: 5.469

4.  Characterization of the 3'-terminal region of the large molecular weight RNA subunits from normal and transformation-defective Rous sarcoma virus.

Authors:  R Pérez-Bercoff; M A Billeter
Journal:  Biochim Biophys Acta       Date:  1976-12-01

5.  Dual action of double-stranded RNA inhibiting protein synthesis in extracts of interferon-treated mouse L cells. Translation is impaired at the level of initiation and by mRNA degradation.

Authors:  J A Lewis; E Falcoff; R Falcoff
Journal:  Eur J Biochem       Date:  1978-05-16

6.  The genomic RNA of mengovirus. II: Comparative analysis of the standard and denser virions.

Authors:  R Perez-Bercoff; M Gander; E Preisig
Journal:  Virology       Date:  1978-04       Impact factor: 3.616

7.  Specific aminoacylation of the methionine-specific tRNA's of eukaryotes.

Authors:  W M Stanley
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

8.  Initiation of protein synthesis: evidence for messenger RNA-independent binding of methionyl-transfer RNA to the 40 S ribosomal subunit.

Authors:  C Darnbrough; S Legon; T Hunt; R J Jackson
Journal:  J Mol Biol       Date:  1973-05-25       Impact factor: 5.469

9.  Purification of interferon from mouse Ehrlich ascites tumor cells.

Authors:  M Kawakita; B Cabrer; H Taira; M Rebello; E Slattery; H Weideli; P Lengyel
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

10.  The origin and nature of the methionine residue initiating the synthesis of haemoglobin in vivo and in vitro.

Authors:  A R Hunter; R J Jackson
Journal:  Eur J Biochem       Date:  1971-04
View more
  1 in total

1.  Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.

Authors:  M Equestre; D Genovese; F Cavalieri; L Fiore; R Santoro; R Perez Bercoff
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.